# Gemcitabine in Treating Children With Refractory Solid Tumors

> **NCT00005577** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00005577
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-08
- **Primary completion:** 2002-09
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005577, "Gemcitabine in Treating Children With Refractory Solid Tumors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00005577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*